Cationic Cyclic Amine Polymers for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cationic lipid and polymer-based nucleic acid delivery systems face challenges such as toxicity, instability, and low transfection efficiency due to the formation of larger aggregates, which limits their effectiveness in delivering nucleic acids into cells.
Innovation Solution
Development of cationic cyclic amine containing polymers and copolymers, synthesized using RAFT polymerization, which form stable complexes with nucleic acids and can be used in conjunction with novel endosomolytic lipids to enhance transfection efficiency, including the use of well-defined structures and architectures like block, linear, and branched polymers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cationic lipid formulations are used for nucleic acid delivery, then transfection efficiency is improved, but cell toxicity increases
Solution Approach 1:
The patent modifies the chemical structure of cationic lipids by introducing cyclic amine-containing polymers with specific molecular weights and charge densities. This parameter change allows optimization of the balance between transfection efficiency and cell toxicity, achieving effective nucleic acid delivery while reducing harmful effects on cells.
Solution Approach 2:
The invention creates composite transfection reagents by combining cyclic amine-containing polymers with cationic lipids and other auxiliary molecules. This composite approach enables the system to achieve high transfection efficiency through synergistic effects while the polymer component helps mitigate toxicity issues associated with traditional cationic lipid formulations.
2Reliability
If cationic polymers are used for nucleic acid delivery, then nucleic acid condensation and protection are improved, but cytotoxicity increases
Solution Approach 1:
The patent employs cyclic amine-containing polymers with specifically controlled molecular weights, charge densities, and structural configurations. By optimizing these parameters, the system achieves effective nucleic acid condensation and protection from degradation while minimizing cytotoxic effects compared to conventional polycations.
Solution Approach 2:
The invention introduces functional groups and structural features at specific locations within the polymer chain that locally enhance nucleic acid binding and protection capabilities while other regions are designed to reduce cytotoxicity. This localized functional differentiation allows simultaneous achievement of protection and reduced toxicity.
3Productivity
If conventional transfection reagents are used, then nucleic acid delivery is achieved, but aggregate formation reduces stability
Solution Approach 1:
The patent utilizes cyclic amine-containing polymers with optimized molecular weights and charge-to-mass ratios that promote formation of stable, uniform complexes with nucleic acids. These parameter optimizations prevent aggregate formation and enhance the stability of the delivery complexes throughout the cellular delivery process.
Solution Approach 2:
The invention employs polymers with specific architectural features (linear, branched, star-shaped) that segment the interaction between cationic components and nucleic acids, creating more uniform and stable complexes. This segmentation approach prevents large aggregate formation and improves complex stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cationic cyclic amine polymers significantly increase nucleic acid transfer efficiency, reducing toxicity and aggregate formation, leading to improved delivery of DNA, RNA, and RNAi into cells, with up to 4-fold and 36-fold increases in transfection efficiency compared to commercial reagents.
Implementation Method 1
Nucleic acids are highly negatively charged (one negative charge per phosphate group) and the cationic polymers interact with them through electrostatic attraction to form complexes
Implementation Method 2
Liposomes, which have been under development since the 1970's, are microscopic vesicles that comprise amphipathic molecules which contain both hydrophobic and hydrophilic regions
Implementation Method 3
The cationic lipids are sometimes mixed with a fusogenic lipid such as DOPE (dioleoyl phosphatidyl ethanolamine) to form liposomes. The cationic liposomes are then mixed with plasmid DNA and the binary complex of the DNA and liposomes are applied to cells
Data Source
AI summary
Cationic cyclic amine containing polymers and copolymers as well as novel lipids have been designed and synthesized for efficient delivery of nucleic acids to cells in biological systems, specifically for in vitro cell transfection research.